Lei Chen

Yangtze River Pharmaceutical Group (China)

Biochemistry, Genetics and Molecular BiologyMedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model”.

Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model

Frontiers in Pharmacology(2022)10.3389/fphar.2022.971905

N/A

0DataRank · unranked

6 citations

Kamila Koucká, Alžběta Spálenková, Petr Holý, Marie Ehrlichová, Tomas Sychra +8 more

Effect of substituents at the C3´, C3´N, C10 and C2-meta-benzoate positions of taxane derivatives on their activity against resistant cancer cells

Toxicology and Applied Pharmacology(2024)10.1016/j.taap.2024.116993

N/A

0DataRank · unranked

3 citations

Kamila Balušíková, Jaroslav Truksa, Jiří Černý, Martin Jaček, Michael Jelínek +8 more

Molecular impact of NOTCH signaling dysregulation on ovarian cancer progression, chemoresistance, and taxane response

Biomedicine & Pharmacotherapy(2025)10.1016/j.biopha.2025.118532

N/A

0DataRank · unranked

1 citations

Alžběta Spálenková, Karolína Šeborová, Tereza Tesařová, Marie Ehrlichová, Ivona Krus +14 more